Handelsbanken Fonder
RMD icon

Handelsbanken Fonder’s ResMed RMD Stock Holding History

Handelsbanken Fonder’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5M Buy
94,895
+25,419
+37% +$5.27M 0.05% 281
2026
Q1 		$15.6M Sell
69,476
-5,500
-7% -$1.37M 0.05% 284
2025
Q4 		$18.1M Buy
74,976
+4,237
+6% +$1.08M 0.05% 280
2025
Q3 		$19.4M Sell
70,739
-454
-0.6% -$124K 0.06% 270
2025
Q2 		$18.4M Sell
71,193
-12,899
-15% -$3.08M 0.07% 262
2025
Q1 		$18.8M Sell
84,092
-1,937
-2% -$452K 0.08% 238
2024
Q4 		$19.7M Buy
86,029
+4,475
+5% +$1.08M 0.08% 245
2024
Q3 		$19.9M Buy
81,554
+3,171
+4% +$709K 0.08% 232
2024
Q2 		$15M Buy
78,383
+4,716
+6% +$957K 0.07% 263
2024
Q1 		$14.6M Buy
73,667
+3,395
+5% +$622K 0.06% 280
2023
Q4 		$12.1M Buy
70,272
+12,899
+22% +$1.98M 0.06% 297
2023
Q3 		$8.48M Buy
57,373
+644
+1% +$116K 0.05% 340
2023
Q2 		$12.4M Buy
56,729
+6,735
+13% +$1.5M 0.07% 296
2023
Q1 		$10.9M Buy
49,994
+2,165
+5% +$470K 0.06% 307
2022
Q4 		$9.96M Sell
47,829
-601
-1% -$132K 0.06% 307
2022
Q3 		$10.6M Buy
48,430
+873
+2% +$199K 0.07% 265
2022
Q2 		$9.97M Buy
47,557
+489
+1% +$104K 0.06% 291
2022
Q1 		$11.4M Sell
47,068
-2,039
-4% -$493K 0.06% 283
2021
Q4 		$12.8M Sell
49,107
-208
-0.4% -$54K 0.06% 288
2021
Q3 		$13M Buy
49,315
+2,429
+5% +$664K 0.07% 275
2021
Q2 		$11.6M Buy
46,886
+9,864
+27% +$2.07M 0.06% 302
2021
Q1 		$7.18M Buy
37,022
+2,100
+6% +$421K 0.04% 360
2020
Q4 		$7.42M Buy
34,922
+2,302
+7% +$459K 0.05% 339
2020
Q3 		$5.59M Hold
32,620
– – 0.04% 351
2020
Q2 		$6.26M Buy
+32,620
New +$5.34M 0.05% 294
2016
Q1 		– Sell
-13,254
Closed -$712K – 512
2015
Q4 		$712K Buy
+13,254
New +$747K 0.01% 566

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Handelsbanken Fonder's RMD Position: Q2 2026 in Review

Handelsbanken Fonder increased its ResMed (RMD) stake by 37% in Q2 2026, buying an estimated $5.27M and bringing the position to 94,895 shares worth $18.5M. The position accounts for 0.05% of the portfolio, ranked #281.

Handelsbanken Fonder first reported a position in RMD in Q4 2015 and has held it in 26 quarters since. The position peaked at $19.9M in Q3 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Handelsbanken Fonder held 94,895 shares of ResMed worth $18.5M as of Q2 2026.
  • Handelsbanken Fonder bought 25,419 ResMed shares in Q2 2026, an estimated $5.27M.
  • ResMed made up 0.05% of Handelsbanken Fonder's portfolio in Q2 2026, its #281 holding.
  • Handelsbanken Fonder first reported a position in ResMed in Q4 2015 and has held it in 26 quarters since.
  • Handelsbanken Fonder's ResMed position peaked at $19.9M in Q3 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.